Study finds Liverpool Care Pathway may not improve care, survival

A randomized clinical trial of Italian cancer patients in 16 hospital wards showed those treated using the end-of-life Liverpool Care Pathway did not have better survival times or significantly improved care compared with patients who received standard care. Use of the LCP is being phased out in the U.K., and study co-author Irene Higginson said the data show it will be important for future programs to be "grounded in scientific evidence and tested in controlled trials before being rolled out across the board."

View Full Article in:

Telegraph (London) (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY